Skip to main content

Table 3 Odds ratios for the presence of MetS components (WHO criteria) according to joint categories of TV viewing time and snack food consumption in Australian men and women

From: Independent and joint associations of TV viewing time and snack food consumption with the metabolic syndrome and its components; a cross-sectional study in Australian adults

  

Adjusted OR (95%CI) for MetS Components based on WHO criteria

  

0-2 hr/d TV & 0–3 snacks/d

0-2 hr/d TV & >3 snacks/d

P

>2 hr/d TV & 0–3 snacks/d

P

>2 hr/d TV & >3 snacks/d

P

N=

 

M

1,167

482

 

604

 

319

 
 

W

1,870

355

 

717

 

168

 

Insulin Resistance

Model A

M

1.00

0.73 (0.48, 1.11)

0.14

1.41 (0.99, 2.00)

0.05

1.51 (0.99, 2.30)

0.05

 

W

1.00

1.27 (0.84, 1.91)

0.25

1.88 (1.38, 2.55)

>0.001

2.15 (1.35, 3.44)

0.002

Model B

M

1.00

0.75 (0.48, 1.16)

0.19

1.45 (1.04, 2.01)

0.03

1.54 (1.02, 2.34)

0.04

 

W

1.00

1.18 (0.76, 1.83)

0.45

1.82 (1.26, 2.64)

0.002

2.14 (1.44, 3.18)

>0.001

Model C

M

1.00

0.70 (0.45, 1.09)

0.11

1.39 (1.01, 1.92)

0.05

1.42 (0.93, 2.18)

0.11

 

W

1.00

1.11 (0.72, 1.70)

0.63

1.83 (1.26, 2.65)

0.002

2.11 (1.36, 3.29)

0.002

Model D

M

1.00

0.68 (0.43, 1.06)

0.08

1.02 (0.78, 1.33)

0.89

1.09 (0.64, 1.85)

0.74

 

W

1.00

0.97 (0.60, 1.55)

0.88

1.60 (1.10, 2.32)

0.02

1.82 (1.25, 2.65)

0.003

Diabetes/IGT/IFG

Model A

M

1.00

0.76 (0.49, 1.18)

0.22

1.31 (0.93, 1.85)

0.12

1.37 (0.93, 2.02)

0.11

 

W

1.00

1.13 (0.74, 1.73)

0.57

1.61 (1.18, 2.19)

0.004

2.34 (1.51, 3.63)

>0.001

Model B

M

1.00

0.85 (0.51, 1.41)

0.53

1.10 (0.75, 1.60)

0.62

1.30 (0.82, 2.04)

0.25

 

W

1.00

0.97 (0.60, 1.57)

0.91

1.13 (0.81, 1.58)

0.46

1.68, 0.81, 3.50)

0.16

Model C

M

1.00

0.82 (0.50, 1.34)

0.42

1.07 (0.73, 1.58)

0.72

1.23 (0.78, 1.94)

0.37

 

W

1.00

0.95 (0.58, 1.56)

0.83

1.14 (0.82, 1.58)

0.43

1.67 (0.82, 3.41)

0.16

Model D

M

1.00

0.83 (0.51, 1.34)

0.42

0.92 (0.63, 1.35)

0.66

1.07 (0.67, 1.71)

0.78

 

W

1.00

0.91 (0.55, 1.50)

0.70

1.02 (0.72, 1.43)

0.92

1.54 (0.60, 3.97)

0.36

Obesity

Model A

M

1.00

0.90 (0.61, 1.31)

0.56

1.49 (1.10, 2.01)

0.01

1.70 (1.23, 2.34)

0.002

 

W

1.00

1.23 (0.86, 1.76)

0.25

1.69 (1.18, 2.41)

0.01

2.48 (1.22, 5.04)

0.01

Model B

M

1.00

0.92 (0.62, 1.37)

0.68

1.45 (1.10, 1.92)

0.01

1.68 (1.20, 2.34)

0.003

 

W

1.00

1.19 (0.82, 1.74)

0.35

1.54 (1.05, 2.25)

0.03

2.18 (1.03, 4.62)

0.04

Model C

M

1.00

0.87 (0.58, 1.31)

0.50

1.40 (1.06, 1.85)

0.02

1.57 (1.11, 2.23)

0.01

 

W

1.00

1.21 (0.83, 1.76)

0.31

1.53 (1.05, 2.25)

0.03

2.19 (1.05, 4.57)

0.04

Hypertension

Model A

M

1.00

0.89 (0.65, 1.22)

0.45

1.15 (0.78, 1.70)

0.47

1.26 (0.76, 2.10)

0.36

 

W

1.00

1.16 (0.70, 1.92)

0.56

1.26 (0.96, 1.65)

0.10

2.34 (1.21, 4.53)

0.01

Model B

M

1.00

0.95 (0.71, 1.26)

0.70

1.15 (0.78, 1.69)

0.48

1.32 (0.78, 2.23)

0.29

 

W

1.00

1.24 (0.76, 2.01)

0.38

1.26 (0.92, 1.72)

0.15

2.32 (1.17, 4.59)

0.02

Model C

M

1.00

0.90 (0.67, 1.23)

0.51

1.12 (0.77, 1.62)

0.56

1.24 (0.72, 2.12)

0.43

 

W

1.00

1.23 (0.75, 2.01)

0.41

1.26 (0.92, 1.73)

0.15

2.32 (1.18, 4.55)

0.02

Model D

M

1.00

0.92 (0.67, 1.25)

0.57

1.00 (0.70, 1.42)

0.98

1.11 (0.65, 1.90)

0.70

 

W

1.00

1.20 (0.73, 1.98)

0.47

1.17 (0.85, 1.60)

0.32

2.24 (1.00, 5.00)

0.05

Dyslipidaemia

Model A

M

1.00

0.84 (0.60,1.17)

0.29

1.31 (1.03, 1.67)

0.03

1.14 (0.77, 1.69)

0.51

 

W

1.00

1.23 (0.71,2.13)

0.45

2.01 (1.44,2.80)

>0.001

1.90 (0.99, 3.63)

0.05

Model B

M

1.00

0.90 (0.63, 1.28)

0.55

1.33 (1.06, 1.67)

0.02

1.17 (0.78, 1.77)

0.43

 

W

1.00

1.20 (0.68, 2.13)

0.51

1.85 (1.33, 2.59)

0.001

1.69 (0.85, 3.38)

0.13

Model C

M

1.00

0.87 (0.63, 1.22)

0.41

1.31 (1.05, 1.64)

0.02

1.13 (0.78, 1.65)

0.50

 

W

1.00

1.23 (0.69, 2.16)

0.47

1.85 (1.32, 2.59)

0.001

1.70 (0.85, 3.38)

0.13

Model D

M

1.00

0.86 (0.62, 1.21)

0.38

1.10 (0.88, 1.39)

0.37

0.96 (0.61, 1.49)

0.85

 

W

1.00

1.15 (0.65, 2.03)

0.63

1.65 (1.21, 2.24)

0.002

1.46 (0.75, 2.83)

0.26

Microalbuminuria

Model A

 

1.00

1.01 (0.39, 2.61)

0.98

0.80 (0.43, 1.48)

0.46

1.26 (0.65, 2.43)

0.48

  

1.00

1.14 (0.48, 2.73)

0.76

1.09 (0.57, 2.09)

0.79

2.97 (1.04, 8.48)

0.04

Model B

M

1.00

1.08 (0.48, 2.80)

0.87

0.68 (0.36, 1.28)

0.23

1.26 (0.60, 2.68)

0.53

 

W

1.00

1.04 (0.30, 3.60)

0.95

0.85 (0.26, 2.78)

0.79

0.31 (0.04, 2.33)

0.25

Model C

M

1.00

0.53 (0.20, 1.46)

0.22

0.86 (0.45, 1.65)

0.65

0.78 (0.32, 1.89)

0.57

 

W

1.00

0.94 (0.27, 3.24)

0.92

0.87 (0.28, 2.72)

0.80

0.29 (0.04, 2.25)

0.23

Model D

M

1.00

0.53 (0.19, 1.47)

0.22

0.83 (0.45, 1.54)

0.55

0.75 (0.30, 1.85)

0.52

 

W

1.00

0.94 (0.28, 3.15)

0.92

0.85 (0.27, 2.72)

0.78

0.28 (0.04, 1.98)

0.19

  1. Data presented as adjusted odds ratio with 95% confidence intervals in parentheses.
  2. Model A: adjusted for age (years) only.
  3. Model B: adjusted for age (years), education level (completed university or higher education/no further education), smoking status (current smoker/ non-smoker), employment status (employed/unemployed), parental history of diabetes (yes/no), leisure-time physical activity (mins/wk) and daily alcohol intake (KJ/d).
  4. Model C: adjusted for Model B + diet quality.
  5. Model D: adjusted for Model C + waist circumference.
  6. IGT = impaired glucose tolerance; IFG = impaired fasting glucose.